Neuberger Berman Group
MRVI icon

Neuberger Berman Group’s Maravai LifeSciences MRVI Stock Holding History

Neuberger Berman Group’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$31.7K Buy
11,200
+7
+0.1% +$24 ﹤0.01% 2130
2025
Q4 		$36.4K Buy
+11,193
New +$37.7K ﹤0.01% 2070
2025
Q3 		– Sell
-11,782
Closed -$28.4K – 2112
2025
Q2 		$28.4K Buy
+11,782
New +$24.8K ﹤0.01% 2011

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Neuberger Berman Group's MRVI Position: Q1 2026 in Review

Neuberger Berman Group increased its Maravai LifeSciences (MRVI) stake by 0.06% in Q1 2026, buying an estimated $24 and bringing the position to 11,200 shares worth $31.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2130.

Neuberger Berman Group first reported a position in MRVI in Q2 2025 and has held it in 3 quarters since. The position peaked at $36.4K in Q4 2025. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

  • Neuberger Berman Group held 11,200 shares of Maravai LifeSciences worth $31.7K as of Q1 2026.
  • Neuberger Berman Group bought 7 Maravai LifeSciences shares in Q1 2026, an estimated $24.
  • Maravai LifeSciences made up ﹤0.01% of Neuberger Berman Group's portfolio in Q1 2026, its #2130 holding.
  • Neuberger Berman Group first reported a position in Maravai LifeSciences in Q2 2025 and has held it in 3 quarters since.
  • Neuberger Berman Group's Maravai LifeSciences position peaked at $36.4K in Q4 2025.
  • 158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on Neuberger Berman Group's 13F filing for Q1 2026, filed 14 May 2026.